These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
150 related items for PubMed ID: 9625444
1. Expression of fibroblast growth factor-2 and fibroblast growth factor receptor-1 in thyroid diseases: difference between neoplasms and hyperplastic lesions. Shingu K, Fujimori M, Ito K, Hama Y, Kasuga Y, Kobayashi S, Itoh N, Amano J. Endocr J; 1998 Feb; 45(1):35-43. PubMed ID: 9625444 [Abstract] [Full Text] [Related]
2. Immunohistochemical localization of acidic and basic fibroblast growth factors in human benign and malignant thyroid lesions. Kodama M, Daa T, Kashima K, Yokoyama S, Nakayama I, Noguchi S. Jpn J Clin Oncol; 1994 Apr; 24(2):66-73. PubMed ID: 7512670 [Abstract] [Full Text] [Related]
5. Expression of basic fibroblast growth factor in thyroid disorders. Shingu K, Sugenoya A, Itoh N, Kato R. World J Surg; 1994 Mar; 18(4):500-5. PubMed ID: 7725735 [Abstract] [Full Text] [Related]
6. The expression and localization of fibroblast growth factor-1 (FGF-1) and FGF receptor-1 (FGFR-1) in human breast cancer. Yoshimura N, Sano H, Hashiramoto A, Yamada R, Nakajima H, Kondo M, Oka T. Clin Immunol Immunopathol; 1998 Oct; 89(1):28-34. PubMed ID: 9756721 [Abstract] [Full Text] [Related]
7. [Immunohistochemical study of epidermal growth factor receptor and estrogen receptor in human thyroid tumors]. Yane K, Tanaka O, Miyahara H, Matsunaga T, Kitahori Y, Hiasa Y. Nihon Jibiinkoka Gakkai Kaiho; 1993 May; 96(5):787-90. PubMed ID: 8315535 [Abstract] [Full Text] [Related]
8. EGF-receptors in human normal and pathological thyroid tissue. Westermark K, Lundqvist M, Wallin G, Dahlman T, Hacker GW, Heldin NE, Grimelius L. Histopathology; 1996 Mar; 28(3):221-7. PubMed ID: 8729040 [Abstract] [Full Text] [Related]
9. Changes in the immunohistochemical localisation of fibroblast growth factor-2, transforming growth factor-beta 1 and thrombospondin-1 are associated with early angiogenic events in the hyperplastic rat thyroid. Patel VA, Hill DJ, Eggo MC, Sheppard MC, Becks GP, Logan A. J Endocrinol; 1996 Mar; 148(3):485-99. PubMed ID: 8778227 [Abstract] [Full Text] [Related]
10. Immunohistochemical localization of growth factors fibroblast growth factor-1 and fibroblast growth factor-2 and receptors fibroblast growth factor receptor-2 and fibroblast growth factor receptor-3 in normal oral epithelium, epithelial dysplasias, and squamous cell carcinoma. Wakulich C, Jackson-Boeters L, Daley TD, Wysocki GP. Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2002 May; 93(5):573-9. PubMed ID: 12075207 [Abstract] [Full Text] [Related]
11. Immunohistochemical demonstration of epidermal growth factor receptor and ceruloplasmin in thyroid diseases. Song B. Acta Pathol Jpn; 1991 May; 41(5):336-43. PubMed ID: 1867098 [Abstract] [Full Text] [Related]
12. [HBME-1 immunostaining in thyroid pathology]. Rigau V, Martel B, Evrard C, Rousselot P, Galateau-Salle F. Ann Pathol; 2001 Feb; 21(1):15-20. PubMed ID: 11223556 [Abstract] [Full Text] [Related]
13. Estrogen receptors (alpha and beta) and 17beta-hydroxysteroid dehydrogenase type 1 and 2 in thyroid disorders: possible in situ estrogen synthesis and actions. Kawabata W, Suzuki T, Moriya T, Fujimori K, Naganuma H, Inoue S, Kinouchi Y, Kameyama K, Takami H, Shimosegawa T, Sasano H. Mod Pathol; 2003 May; 16(5):437-44. PubMed ID: 12748250 [Abstract] [Full Text] [Related]
14. Increase of basic fibroblast growth factor (FGF) and FGF receptor messenger RNA during rat thyroid hyperplasia: temporal changes and cellular distribution. Becks GP, Logan A, Phillips ID, Wang JF, Smith C, DeSousa D, Hill DJ. J Endocrinol; 1994 Aug; 142(2):325-38. PubMed ID: 7931005 [Abstract] [Full Text] [Related]
15. Fibroblast growth factor receptors as molecular targets in thyroid carcinoma. St Bernard R, Zheng L, Liu W, Winer D, Asa SL, Ezzat S. Endocrinology; 2005 Mar; 146(3):1145-53. PubMed ID: 15564323 [Abstract] [Full Text] [Related]
16. Detection of high mobility group I HMGI(Y) protein in the diagnosis of thyroid tumors: HMGI(Y) expression represents a potential diagnostic indicator of carcinoma. Chiappetta G, Tallini G, De Biasio MC, Manfioletti G, Martinez-Tello FJ, Pentimalli F, de Nigris F, Mastro A, Botti G, Fedele M, Berger N, Santoro M, Giancotti V, Fusco A. Cancer Res; 1998 Sep 15; 58(18):4193-8. PubMed ID: 9751634 [Abstract] [Full Text] [Related]
17. Immunohistochemical demonstration of thyrotropin (TSH)-receptor in normal and diseased human thyroid tissues using monoclonal antibody against recombinant human TSH-receptor protein. Mizukami Y, Hashimoto T, Nonomura A, Michigishi T, Nakamura S, Noguchi M, Matsukawa S. J Clin Endocrinol Metab; 1994 Aug 15; 79(2):616-9. PubMed ID: 8045985 [Abstract] [Full Text] [Related]
18. [Expression of cytokeratin19, galectin-3 and HBME-1 in thyroid lesions and their differential diagnoses]. Teng XD, Wang LJ, Yao HT, Li J, Ding W, Yan LP. Zhonghua Bing Li Xue Za Zhi; 2004 Jun 15; 33(3):212-6. PubMed ID: 15256110 [Abstract] [Full Text] [Related]
19. Galectin-3 messenger ribonucleic acid and protein are expressed in benign thyroid tumors. Martins L, Matsuo SE, Ebina KN, Kulcsar MA, Friguglietti CU, Kimura ET. J Clin Endocrinol Metab; 2002 Oct 15; 87(10):4806-10. PubMed ID: 12364477 [Abstract] [Full Text] [Related]
20. Basic fibroblast growth factor: an autocrine mitogen of rat thyroid follicular cells? Logan A, Black EG, Gonzalez AM, Buscaglia M, Sheppard MC. Endocrinology; 1992 Apr 15; 130(4):2363-72. PubMed ID: 1312454 [Abstract] [Full Text] [Related] Page: [Next] [New Search]